Podcasts about FACS

In this episode, Tom Varghese, MD, FACS, is joined by Brett Johnson, MD, and Clifford Ko, MD, FACS, from the American College of Surgeons (ACS). They discuss the recent article by Drs Johnson and Ko, “Evaluating Outcomes of Initial Site Visits Across American College of Surgeons Accreditation Programs,” in which the authors found that ACS accreditation identifies significant gaps in hospital quality, with only 61% of hospitals passing on their initial attempt. However, most ultimately succeed after remediation. These findings highlight that ACS accreditation both validates hospitals meeting rigorous standards and drives quality improvement in those that initially fall short. Disclosure Information: Drs Varghese, speaker, has no relevant financial conflicts to disclose. Drs Johnson and Ko, speakers, are employees of the American College of Surgeons. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord

Guest: Paul Turek, MD, FACS, FRSM, Founder of The Turek Clinic Host: Dan Bulger, Progyny    The Fertility 101 Series, because there's no shortage of daunting terms to keep your mind running, is a quick and dirty breakdown on a specific topic with insights from a fertility expert.  When it comes to fertility, men are half of the equation, but too often, they're the half that gets forgotten or overlooked. This Men's Health Month, we're joined by Dr. Paul Turek, a world-renowned urologist and male fertility expert, to talk all things sperm, from how it's made to how it affects fertility and IVF.  Dr. Turek explains how sperm health isn't just about making babies, it's also a sign of a man's overall health, tied to things like life expectancy, cancer risk, and heart health. Dr. Turek also tells us about his podcast, Talk with Turek, where he and Rob Clyde expose men's health and talk about it frankly – tackling the issues that matter. So, if you want to hear more on men's health from Dr. Turek, you're in luck!  And if you've never thought about getting a semen analysis, this episode might change that. Whether you're thinking about starting a family, planning for the future, or just want to stay healthy, your sperm may tell you more than you could believe.  For more information, visit Progyny's Podcast page and Progyny's Education page for more resources. Be sure to follow us on Instagram, @ThisisInfertilityPodcast and use the #ThisisInfertility. Have a question, comment, or want to share your story? Email us at thisisinfertility@progyny.com.     Video Version: https://youtu.be/VNTff8wEGmk 

My conversation with Dr Dua begins at about 35 mins Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous souls Healthcare For Action was founded in 2022 to support healthcare workers running for Congress. Dr. Anahita Dua, Chair of Healthcare for Action, is a Vascular Surgeon at Massachusetts General Hospital and an Associate Professor of Surgery at Harvard University. As a surgeon, she knows that in order to get things done and save lives, the surgery team has to work together and take action. Our politics shouldn't be any different.  In 2023, Healthcare For Action merged with Doctors In Politics, founded in 2020 by a group of physicians specializing in psychiatry, family medicine, OBGYN, and neurology. They were committed to patient-centered and equitable political change at all levels of government and grew to a membership of nearly 10,000. We believe fundamentally that all policy is health policy.  There are too many existential threats facing our democracy. From reversing climate change, preserving access to abortion, and curbing the epidemic of gun violence we must take action now and play the long game. From acute care to prevention, healthcare workers know how to get the job done. That is the guiding vision of the largest Democratic healthcare workers PAC in the country - Join our community at Healthcare For Action! Anahita Dua, MD, MS, MBA, FACS, is a vascular surgeon at Massachusetts General Hospital and an associate professor of Surgery at Harvard Medical School. At Mass General, she is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, director of the Lymphedema Center and associate director of the Vascular Surgery Clerkship and director of clinical research for the division of vascular surgery. She specializes in advanced endovascular (minimally invasive) and traditional (open) limb salvage techniques for treating peripheral arterial disease and critical limb ischemia, diabetic limb disease, aortic disease, carotid disease, thoracic outlet syndrome and venous disease. Dr. Dua completed her vascular surgery fellowship at Stanford University Hospital, her general surgery residency at the Medical College of Wisconsin and her medical school in the United Kingdom. She has also completed a master's degree in trauma sciences, a master's in business administration in health care management and has a certificate in health economics and outcomes research as well as a certificate in drug and device development from the Massachusetts Institute of Technology. She is board-certified in vascular surgery, general surgery and advanced wound care and management. Dr. Dua has published over 140 peer reviewed papers and has edited five vascular surgery medical textbooks. She serves on multiple national vascular surgery committees through the Society for Vascular Surgery and other vascular organizations including the South Asian-American Vascular Society and American College of Surgeons. Dr. Dua's lab focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization. She is interested in creation precision, point of care medical approaches to anticoagulation for patients post revascularization. Her clinical and outcomes research focuses primarily on diseases involving peripheral vascular disease, limb salvage and critical limb ischemia. She is part of a technology development team that creates tools to increase walking distance and wound healing while decreasing pain in patients with peripheral vascular disease. Dr. Dua is also involved heavily in surgical outcomes-based research using large medical databases to generate both quality outcomes and cost effectiveness data. Dr. Dua is a self-described animal lover and rescuer of pitbulls. At one point, she housed 14 pitbull puppies and their mother at once. Nowadays, her spare time is spent with her husband, son, daughter and dog Leo. Join us Monday and Thursday's at 8EST for our  Bi Weekly Happy Hour Hangout!  Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on YouTube  Pete on Twitter Pete On Instagram Pete Personal FB page Stand Up with Pete FB page All things Jon Carroll  Follow and Support Pete Coe Buy Ava's Art  Hire DJ Monzyk to build your website or help you with Marketing  

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/UKV865. CME/MOC/CC/AAPA credit will be available until June 13, 2026.Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/UKV865. CME/MOC/CC/AAPA credit will be available until June 13, 2026.Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/UKV865. CME/MOC/CC/AAPA credit will be available until June 13, 2026.Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/UKV865. CME/MOC/CC/AAPA credit will be available until June 13, 2026.Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/UKV865. CME/MOC/CC/AAPA credit will be available until June 13, 2026.Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/UKV865. CME/MOC/CC/AAPA credit will be available until June 13, 2026.Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

John Dussel, MD, FACS, RPVI, Oregon Vascular SpecialistsCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/BBXW4fZvax (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: June 3, 2025End Date: June 3, 2026

John Dussel, MD, FACS, RPVI, Oregon Vascular SpecialistsCME Credit Available for all Providence ProvidersIn order to claim CME credit, please click on the following link: https://forms.office.com/r/BBXW4fZvax (or copy & paste into your browser)Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1  creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Planning Committee & Faculty Disclosure: The planning committee and faculty have indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. All financial relationships (if any) have been mitigated.Original Date: June 3, 2025End Date: June 3, 2026

Dr. Alipi Bonm, a neuro-oncologist at the Providence Swedish Cancer Institute in Seattle, joins host Dr. Ashwani Rajput to offer up valuable insights into brain cancer, from what to expect to the promising treatment options available that could ease your fears. He also debunks common myths, such as the misconception that cell phones and electrical wires cause brain cancer and highlights promising future treatments. If you or a loved one are affected by brain cancer, discover the support groups available for both patients and caregivers. Don't miss out on this informative and supportive discussion.Dr. Ashwani Rajput BioSee below Do you want to know more?Check out the Providence blog for more information on melanoma and other cancer related topics. Personalized cancer peptide vaccine shows remarkable promise against glioblastomaProvidence Saint John's opens last phase of clinical trial of promising drug for aggressive brain cancerTo learn more about our mission programs and services, go to Providence.org.Follow us on social media to get continued information on other important health care topics. You can  connect with us on LinkedIn, Facebook, TikTok, Instagram and X.For all your healthcare information on the go, download the Providence app. Whether you're tracking symptoms, scheduling appointments, or connecting with your healthcare providers, the Providence app has your back.To learn more about the app, check out the Wellness Brief podcast episode. Wellness Brief: Simplifying Care-There's an App for That.We'd love to hear from you. You can contact us at FutureOfHealthPodcasts@providence.org Dr. Ashwani Rajput BioAshwani Rajput, MD, FACS, joined Providence Swedish in September 2024 as the regional executive medical director (EMD) of the Swedish Cancer Institute. Dr. Rajput comes to us from Johns Hopkins University, where he is a professor of Surgery and Oncology, as well as the director of the Hopkins Kimmel Cancer Center in the Washington, D.C. region. Dr. Rajput completed his medical school, general surgery training, and a post-doctoral fellowship in molecular genetics at Case Western Reserve University in Cleveland, Ohio. He went on to the Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., for a fellowship in Complex General Surgical Oncology (CGSO). There, he was recruited to join the faculty at Roswell Park with appointments in GI Surgical Oncology as well as Pharmacology and Therapeutics. His laboratory investigated the key signal transduction pathways in colorectal metastases using novel orthotopic murine models. In 2009, Dr. Rajput was recruited to the University of New Mexico as the inaugural division chief of Surgical Oncology. During his tenure in New Mexico, he also served as the director of surgical services for the NCI-designated Comprehensive Cancer Center and vice-chair of surgery for academic affairs and faculty development. Under his leadership, an ACGME-approved fellowship in CGSO was created and launched. Throughout his roles in New Mexico and D.C., he has actively addressed cancer health care outcomes and health equity. Under Dr. Rajput's leadership, he will develop and implement a cancer strategic vision and enhance collaboration across our geography. He will oversee the SCI medical directors and partner with the Senior Director of Operations to deliver excellence in cancer care. Dr. Rajput and his wife, Sunita, have four children. Outside of work, he enjoys playing tennis, piano, the arts, and traveling.

Join Dr. Kristi Funk as she debunks the myth about protein intake and reveals top plant-based sources. Learn why you don't need to worry about protein deficiency and discover the power of soy, lentils, beans, and more. Transform your diet with these delicious and nutritious options! #PlantBasedProtein #HealthyEating #BreastCancerPrevention

Dr. Tracy Gapin, MD, FACS, is a renowned expert in men's health optimization and longevity, with over 25 years of experience as a board-certified urologist. He founded the Gapin Institute to help high-performing individuals, including entrepreneurs, executives, and athletes, achieve peak performance through personalized health programs. Dr. Gapin integrates advanced diagnostics, epigenetics, hormone therapy, and wearable technology to monitor and transform his clients' health, focusing on sustainable, measurable outcomes. A thought leader and author of bestsellers Male 2.0 and Codes of Longevity, Dr. Gapin has been featured on NBC, Entrepreneur Magazine, and at Dave Asprey's Biohacking Conference. He is a member of the American Academy of Anti-Aging, the Age Management Medical Group, and the International Peptide Society. In this episode Dr. Tracy dives in to talk about what re-shaped his thinking on the traditional reactive medical system, and the path he was inspired to take to become a proactive solution for high-performing entrepreneurs and leaders. Dr. Tracy walks us through how we may overestimate what we think we know about our health which are our health blind spots. These can show up when we dive deeper beyond the surface to explore things such as hormones, inflammation, and our gut health. Dr. Tracy shares his personal story of dis-ease and what it finally took for him not only to face his health head-on but also the medical system he operated within. Patrick and Dr. Tracy explore his paradigm shift around men's and women's health, endocrine disruptors, peptides, protein and carbs, aging and regenerative medicine. They round out their conversation with mindset – habits, choice, discipline and transformation. You don't want to miss it!

James R. Korndorffer Jr., M.D., MHPE, FACS, joined the University of Texas Austin, Dell Medical School in January of 2025 and leads the continuum of medical education to train the next generation of physicians and health care professionals. In addition, he leads efforts across The University of Texas at Austin and The University of Texas System to support interprofessional education, curricular innovation, research and other learning activities.Korndorffer graduated cum laude from Tulane University with an undergraduate degree in biomedical engineering. He received his medical degree from the University of South Florida College of Medicine. He completed his general surgery internship and residency at the Carolinas Medical Center in Charlotte, North Carolina, where he received the award for best resident teacher.With a strong interest in teaching, Korndorffer left a successful private practice after eight years and joined the faculty at Tulane University School of Medicine He became an associate professor of surgery in 2005 and professor in 2010. He served in numerous leadership roles at Tulane, including vice chair of the surgery department from 2012 to 2017, program director for the surgical residency from 2006 to 2017, assistant dean for graduate medical education and founding medical director for the Tulane Center for Advance Medical Simulation. Continuing his passion for education, Korndorffer completed his Master of Health Professions Education at the University of Illinois Chicago while working full time at Tulane.Korndorffer joined Stanford School of Medicine's Department of Surgery as the inaugural vice chair for education in 2017. He assumed additional leadership responsibilities within the department, including director of the Goodman Surgical Simulation Center and the surgical education fellowship program.He was one of the early adopters of the use of simulation for surgical training and has been actively involved in surgical education research since 2003. Some of the early work using proficiency-based training instead of time base training for skill acquisition. This has now become the norm. He is now actively involved investigating the role simulation education has in patient quality and healthcare system safety.Korndorffer has published over 100 papers in peer-reviewed journals as well as 10 book chapters, and he has held over 150 presentations at national and international meetings.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

In this episode, Tom Varghese, MD, FACS, is joined by Todd Heniford, MD, FACS, and Alexis Holland, MD, from the Carolinas Medical Center. They discuss the recent article by Drs Heniford and Holland, “Limited or Lasting: Is Preoperative Weight Loss as Part of Prehabilitation Maintained after Open Ventral Hernia Repair?” This study supports the implementation of preoperative optimization and weight loss before hernia surgery, which remains controversial. Long-term maintenance of preoperative weight loss before abdominal wall reconstruction is achievable and sustainable.   Disclosure Information: Drs Varghese and Holland have nothing to disclose. Dr Heniford is a surgical research grant recipient and receives speaking honoraria from WL Gore.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

In this episode John A. Hovanesian, MD, FACS, and Jim Mazzo are live from SightLine at the ASCRS meeting with guests Nicole R. Fram, MD, Kerry D. Solomon, MD, Vance Thompson, MD, and Steve Speares. Welcome to the Eyeluminaries podcast 00:02 Review of episode 32 00:55 Intro of Nicole Fram, MD 01:16 Tell us why the MAHRVELS team is likely to be the leading fundraisers and why you picked your character for the team to portray (The Scarlet Witch)? 02:24 Meeting about complications from cataract surgery, what do you think is the next big phase on how we're going to handle complications with technology? 04:05 Psychology of managing patients/conveying care 05:42 What advice do you give to people who are starting their career? 06:50 Intro of Kerry Solomon, MD 09:30 What do we often get wrong with cataract surgery and what do we often get right? 10:25 How do you stay an entrepreneur and a leading physician? 11:55 What is Operation Sight? How did you create it? 14:19 Where will keratorefractive surgery and lens-based surgery be in 5 or 10 years? 18:30 Intro of Vance Thompson, MD 21:24 What's it like to be ASCRS president? 21:59 What is BRiCS and why is it important? 23:54 You've created a culture; can you talk about that culture you've created at your institute? 29:30 Tell us about your winery! 33:28 Intro of Steve Speares 36:45 ASCRS just wrapped up. Your idea of creating a SightLine with a business approach, what did you do and what was the idea? 38:00 As you look back and you look ahead, what changes do you hope to make? What do you hope your legacy will be at ACSRS? 40:57 Can you expand more on how Washington, DC and Trump administration will impact your society/group? 44:19 Richard Lindstrom in ASCRS hall of fame, tell us your own perspective and a good story 46:29 Preview of episode 34 52:09 Give us your feedback 52:40 Thanks for listening 52:56 Nicole Fram, MD, is an adjunct assistant professor at the John A. Moran Eye Institute at the University of Utah. She is also the secretary for ASCRS, is a member of the Cataract Clinical Committee, and leads the Ophthalmology Quicksand Chronicles podcast with co-host Elizabeth Yeu, MD. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Kerry Solomon, MD, is internationally renowned for LASIK and refractive cataract surgery. He is the co-founder of Operation Sight. He is the former chairman of the ASCRS FDA Committee. Steve Speares, MD, is the executive director at ASCRS. Vance Thompson, MD, is the founder of Vance Thompson Vision and director of refractive surgery in Sioux Falls, SD. He serves as a professor of ophthalmology at the Sanford School of Medicine at the University of South Dakota. Thompson is the immediate past president of ASCRS. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Fram, Speares, Solomon, and Thompson at the time of publication.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/AAPA/IPCE credit will be available until May 27, 2026.Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/AAPA/IPCE credit will be available until May 27, 2026.Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/AAPA/IPCE credit will be available until May 27, 2026.Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/AAPA/IPCE credit will be available until May 27, 2026.Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/AAPA/IPCE credit will be available until May 27, 2026.Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/AAPA/IPCE credit will be available until May 27, 2026.Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

Join us for the inaugural episode of "TWAD: Cancer, Cures and Coffee" with Dr. Ashwani Rajput and special guest Dr. Kelly Paulson. In this episode, we dive deep into the topic of Melanoma, one of the most serious types of skin cancer. Dr. Paulson, a medical oncologist at Swedish Cancer Institute First Hill in Seattle, shares her expertise on the importance of early detection, risk factors, and the latest advancements in treatment. Learn how to protect yourself and your loved ones from Melanoma and discover the role of the immune system in fighting cancer. Don't miss this informative and engaging discussion.Dr. Ashwani Rajput BioSee below Do you want to know more?Check out the Providence blog for more information on melanoma and other cancer related topics. ·       Cancer survivor speaks with doctor he credits for saving his life·       Saint Patrick HealthBreak - Skin Cancers·       A year to remember: Advancements, recognition and transitions To learn more about our mission programs and services, go to Providence.org.Follow us on social media to get continued information on other important health care topics. You can  connect with us on LinkedIn, Facebook, TikTok, Instagram and X.For all your healthcare information on the go, download the Providence app. Whether you're tracking symptoms, scheduling appointments, or connecting with your healthcare providers, the Providence app has your back.To learn more about the app, check out the Wellness Brief podcast episode. Wellness Brief: Simplifying Care-There's an App for That. We'd love to hear from you. You can contact us at FutureOfHealthPodcasts@providence.org Dr. Ashwani Rajput BioAshwani Rajput, MD, FACS, joined Providence Swedish in September 2024 as the regional executive medical director (EMD) of the Swedish Cancer Institute. Dr. Rajput comes to us from Johns Hopkins University, where he is a professor of Surgery and Oncology, as well as the director of the Hopkins Kimmel Cancer Center in the Washington, D.C. region. Dr. Rajput completed his medical school, general surgery training, and a post-doctoral fellowship in molecular genetics at Case Western Reserve University in Cleveland, Ohio. He went on to the Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., for a fellowship in Complex General Surgical Oncology (CGSO). There, he was recruited to join the faculty at Roswell Park with appointments in GI Surgical Oncology as well as Pharmacology and Therapeutics. His laboratory investigated the key signal transduction pathways in colorectal metastases using novel orthotopic murine models. In 2009, Dr. Rajput was recruited to the University of New Mexico as the inaugural division chief of Surgical Oncology. During his tenure in New Mexico, he also served as the director of surgical services for the NCI-designated Comprehensive Cancer Center and vice-chair of surgery for academic affairs and faculty development. Under his leadership, an ACGME-approved fellowship in CGSO was created and launched. Throughout his roles in New Mexico and D.C., he has actively addressed cancer health care outcomes and health equity. Under Dr. Rajput's leadership, he will develop and implement a cancer strategic vision and enhance collaboration across our geography. He will oversee the SCI medical directors and partner with the Senior Director of Operations to deliver excellence in cancer care. Dr. Rajput and his wife, Sunita, have four children. Outside of work, he enjoys playing tennis, piano, the arts, and traveling.

In this episode of Quah (Q & A), Sal, Adam & Justin coach four Pump Heads via Zoom. Mind Pump Fit Tip: 8 weird signs that you should avoid gluten. (1:45) Why is fitness so EFFECTIVE for depression and anxiety? (22:07) Don't forget to bring Zbiotics to your next party or gathering. (29:00) The Schafer's Lego Land experience. (32:19) Saffron is a natural compound for depression and anxiety. (45:43) Justin's Road to 315 Push Press. (46:55) 3-part bonus series for trainers dropping on May 19th! (1:00:35) #ListenerLive question #1 – Any advice for jumping and getting into personal training? (1:01:51) #ListenerLive question #2 – Where do I go after I finish Symmetry to make sure I can keep this momentum going to live pretty much pain-free and moving freely? (1:13:03) #ListenerLive question #3 – When would you guys recommend someone get liposuction? (1:22:42) #ListenerLive question #4 – Do I need to educate myself a little more before hiring a coach? And if so, how exactly? (1:32:53) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit Pre-Alcohol by ZBiotics for an exclusive offer for Mind Pump listeners! ** Promo code MINDPUMP25 for 15% off first-time purchasers on either one-time purchases, (3, 6, 12-packs) or subscriptions (6, 12-pack) ** Visit Organifi for the exclusive offer for Mind Pump listeners! **Promo code MINDPUMP at checkout for 20% off** May Special: MAPS 15 Performance or RGB Bundle 50% off! ** Code MAY50 at checkout ** Mood Disorders and Gluten: It's Not All in Your Mind! A Systematic Review with Meta-Analysis Transmission of Faith in Families: The Influence of Religious Ideology Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial Justin's Road to 315 Push Press Train the Trainer Webinar Series Mind Pump Group Coaching Mind Pump #2515: How to Become a Successful Trainer in 2025 Online Personal Training Course | Mind Pump Fitness Coaching ** Approved provider by NASM/AFAA (1.9 CEUs)! Grow your business and succeed in 2025. ** Mind Pump #2242: The Non-Surgical Way to Look Younger With Dr. Anthony Youn Mind Pump #1622: Nine Signs Your Trainer Sucks Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Stan “Rhino” Efferding (@stanefferding) Instagram Jordan Jiunta (@redwiteandjordan) Instagram Marcelo (@mindpumpmarcelo) Instagram Anthony Youn, MD, FACS (@tonyyounmd) Instagram Justin Brink DC (@dr.justinbrink) Instagram Jordan Shallow D.C (@the_muscle_doc) Instagram  

Cancer is among the most common and feared diseases in the modern world. Dr. Selwyn Vickers—president and CEO of Memorial Sloan Kettering Cancer Center—joins host Mark Labberton to discuss how precision oncology, data, and faith are transforming cancer treatment. A distinguished cancer surgeon and pancreatic cancer researcher, Vickers explains how groundbreaking advances in genomics, immunotherapy, and AI are transforming once-lethal diagnoses into survivable and even chronic conditions. Together, they explore not only the cutting-edge science of cancer care but also the spiritual, emotional, and social dimensions that affect every patient and caregiver. Resonating with themes of suffering, hope, and resurrection, this conversation offers clarity, compassion, and courage for all who are affected by cancer—from those newly diagnosed, to medical professionals, to grieving families and curious listeners. Episode Highlights “We're getting to a point where we will, in the next five to seven years, have a much better chance to cure people—and to make pancreatic cancer a chronic illness.” “We are in what's somewhat coined the golden age of cancer research.” “Cancer is a disease that creates an existential threat in ways no other illness does.” “If a tumour forms, it means your body's immune system has made a social contract with the cancer.” “We changed the diagnosis in 10–12 percent of the patients who come to us—sometimes from cancer to no cancer.” “Cancer care is a team sport. And our patients often inspire us more than we help them.” Helpful Links & Resources Memorial Sloan Kettering Cancer Center BioNTech – creators of mRNA vaccines for COVID and cancer CAR T-Cell Therapy Overview (Cancer.gov) Tim Keller on cancer and hope Emma Thompson's Wit (HBO) BRCA1 and BRCA2 Genes and Cancer Risk MSK-IMPACT: Next-Gen Tumor Profiling About Selwyn Vickers Selwyn M. Vickers, MD, FACS, is the president and CEO of Memorial Sloan Kettering Cancer Center (MSK) and the incumbent of the Douglas A. Warner III Chair. He assumed the role on September 19, 2022. Vickers is an internationally recognized pancreatic cancer surgeon, pancreatic cancer researcher, and pioneer in health disparities research. He is a member of the National Academy of Medicine and the Johns Hopkins Society of Scholars. He has served on the Johns Hopkins School of Medicine Board of Trustees and the Johns Hopkins University Board of Trustees. Additionally, he has served as president of the Society for Surgery of the Alimentary Tract and the Southern Surgical Association. Vickers is the immediate past president of the American Surgical Association. He also continues to see patients. In 1994, he joined the faculty of the University of Alabama at Birmingham (UAB) as an assistant professor in the Department of Surgery, where he was later appointed to professor and the John H. Blue Chair of General Surgery. In 2006, Vickers left UAB to become the Jay Phillips Professor and Chair of the Department of Surgery at the University of Minnesota Medical School. Born in Demopolis, Alabama, Vickers grew up in Tuscaloosa and Huntsville. He earned baccalaureate and medical degrees and completed his surgical training (including a chief residency and surgical oncology fellowship) at the Johns Hopkins University. Vickers completed two postgraduate research fellowships with the National Institutes of Health and international surgical training at John Radcliffe Hospital of Oxford University, England. Vickers and his wife, Janice, who is also from Alabama, have been married since 1988. They have four children. Show Notes The ongoing threat and fear of cancer How Selwyn Vickers got into medicine Pancreatic cancer: Vickers's expertise “We are in what's somewhat coined the golden age of cancer research.” Sequencing the human genome “Is there a drug that might target the mutation that ended up creating your cancer?” Cancer as both a medical and existential diagnosis The revolution of precision oncology through human genome sequencing ”It takes a billion cells to have a one centimetre tumor.” Immunotherapy: checkpoint inhibition, CAR T-cell therapy, and vaccines Cellular therapy:   ”Taking a set of their normal cells and re-engineering them to actually go back and target and attack their tumors. … We've seen patients who had initially a 30 percent chance of survival converted to an 80 percent chance of survival.” “We know in many tumours there's something called minimal residual disease.” “Immunizing yourself against cancer is a significant future opportunity.” Managing the power of data with AI and computational oncology Cancer-care data explosion: the role of computational oncologists Cancer vaccines: breakthrough mRNA treatment for pancreatic cancer ”Didn't ultimately win. We had to suffer through her losing her life, but was so appreciative that she got much more than the six months she was promised.” Tumour misdiagnoses and the importance of specialized expertise Pancreatic cancer challenges: immune cloaking and late-stage detection In the past, one in four would die from the operation for removing pancreatic cancer Long-term survival Future of cancer detection: AI-based medical record analysis and blood biopsies More accurate blood tests to confirm conditions Using AI to select those who are high-risk for cancer Pastor Tim Keller died of pancreatic cancer. In the past, “your doctor … helped you learn how to die.” ”[God's] given man the privilege to discover those things that have been hidden. And over time we've gradually uncovered huge opportunities to impact people's lives.” The state of breast cancer research and treatment “If you get the diagnosis of breast cancer, you have a 90 percent chance to survive and beat it over a five-year period of time.” ”In general, we're in a great state of understanding how to treat breast cancer, how to detect it early, and then have selective and targeted mechanisms to prevent it from coming back.” Prostate cancer research and treatment Theranostics: using a specific antibody to target cancer cells specifically Pediatric cancer:  ”We actually treat more children for cancer than any hospital in America now, but in general, the survival for pediatric cancers is greater than 80 percent.” Emotional, psychological, and spiritual toll of cancer: importance of psycho-oncology How Sloan Kettering developed psycho-oncology to help cancer patients with mental and spiritual health Personal story: how a cafeteria worker empowers patients through food choices “We give back to them the right to choose what they get to have on their tray.” Cancer treatment is a team sport. Wit (film, Broadway play)—actress Emma Thompson plays a cancer patient studying the work of John Donne on death Socioeconomic and racial disparities in cancer care outcomes The healing role of community, support teams, and compassionate listening The importance of listening to cancer patients who are preparing to die The spiritual courage of patients and the transformative power of faith “Our patients often help us. We see the grace with which they often handle that journey.” The inspiration behind becoming a doctor: family legacy and human impact Terminal care: the sacred responsibility of walking with patients to the end Cancer research and treatment as a Christian vocation and expression of humanity Production Credits

Raeann Wilson was born in Cabot, AR. As a breast cancer survivor, IV therapy was an integral part of Raeann's recovery, and she became passionate about giving the same level of care to other post-operation patients. As the surgical coordinator at Shewmake Plastic Surgery, Raeann has extensive knowledge in surgical processes and patient care. This all gave her the skill and inspiration to create Zen Infusion, offering mobile, on-demand IV infusion therapy that serves a number of needs for the people of Central Arkansas. Kris Shewmake, M.D., FACS was born in Pine Bluff, AR. He earned his bachelor's degree in biology from Hendrix College in Conway and a master's degree in natural science from the University of Arkansas at Fayetteville. He received his medical degree from UAMS, where he also completed a residency in general surgery. He was president of his class and elected into the Alpha Omega Alpha Medical Honor Society (top 10% of the class). His eight years of surgical training after medical school included a General Surgery residency at the University of Arkansas for Medical Sciences (UAMS) Medical Center and a Plastic and Reconstructive Surgery residency in Dallas at the University of Texas-Southwestern Medical Center. Dr. Shewmake entered private practice in 1996 and was named Best Plastic Surgeon in Arkansas by his colleagues in 1999 and 2009.

In this episode, Arthur L. Jenkins III, MD, FACS, FAANS, Director of Spine Program at Institutes for Specialized Surgery, LLC, joins the podcast to discuss how he's working to simplify the surgery experience for patients. He also dives into his focus on clinical and operational excellence, the political climate surrounding the healthcare space, and pay discrepancies tied to volume over quality.

This week, AmSpa founder and CEO, Alex R. Thiersch, JD, sits down with Dr. Christopher C. Surek, DO, FACS—board-certified plastic surgeon, internationally recognized facial anatomist, and founder and director of the Academy for Injection Anatomy (AIA)—to discuss the new AIA Alumni Reunion and Refresher course. Designed exclusively for advanced cadaver training alumni, this event offers a higher level, more intense training experience with live full face injections, layered and cross-sectional dissections, and simultaneous ultrasound assessments. Dr. Surek also talks about his new textbook, co-authored with Dr. Steven Weiner, and the power of mentorship and networking within the AIA community. Learn why building your safety community is just as essential as mastering anatomy and register for the AIA Alumni Reunion and Refresher course at americanmedspa.org/aiaalumni. --- Music by Ghost Score

This episode offers an overview of the recent ACS Leadership & Advocacy Summit, held in Washington, DC, including popular sessions on knowing your worth as a surgical leader and learning how to lead at every level. Michael J. Sutherland, MD, MBA, FACS, Senior Vice President of ACS Member Services, discusses these sessions and more with Kimberly M. Lumpkins, MD, MBA, FACS, the Dr. J. Laurance Hill Endowed Professor in Pediatric Surgery at the University of Maryland School of Medicine in Baltimore, and Joshua M. V. Mammen, MD, PhD, FACS,  the Merle M. Musselman Centennial Professor of Surgery at the University of Nebraska Medical Center in Omaha.     HOST: Michael J. Sutherland, MD, MBA, FACS, Senior Vice President, ACS Division of Member Services, Chicago, IL    GUESTS: Kimberly M. Lumpkins, MD, MBA, FACS, Pediatric Surgeon-in-Chief at the University of Maryland Children's Hospital and the Dr. J. Laurance Hill Endowed Professor in Pediatric Surgery at the University of Maryland School of Medicine, Baltimore, MD    Joshua M. V. Mammen, MD, PhD, FACS, Merle M. Musselman Centennial Professor of Surgery and Chief of the Department of Surgery at the University of Nebraska Medical Center, Omaha, NE    Talk about the podcast on social media using the hashtag #HouseofSurgery 

Are you struggling with chronic constipation, incomplete evacuation or irregular bowel movements despite trying diet and lifestyle changes? These symptoms might point to underlying issues with gut motility, nervous system signaling or imbalances in the gut microbiome. Gain a clearer understanding of your digestive health and learn about the physiology, causes and solutions for improving bowel function and avoiding hemorrhoids and anal fissures with Dr. Carmen Fong, MD, FACS. Lindsey Parsons, your host, helps clients solve gut issues and reverse autoimmune disease naturally. Take her quiz to see which stool or functional medicine test will help you find out what's wrong. She's a Certified Health Coach at High Desert Health in Tucson, Arizona. She coaches clients locally and nationwide. You can also follow Lindsey on Facebook, Tiktok, X, Instagram or Pinterest or reach her via email at lindsey@highdeserthealthcoaching.com to set up your free 30-minute Gut Healing Breakthrough Session. Show Notes

In this special MSS edition of Medical Spa Insider, Michela Bailey sits down with the leaders of the Texas State Chapter, recorded live at Medical Spa Show 2025! Meet Texas co-chairs S. Alexis Gordon, MD, FACS, of Renew MD Facial Aesthetics, and Celeste Cisneros, MSN, APRN, FNP-BC, of Solas Health and Wellness; and secretary Tammy Pendygraft, CLHRP, of Revive Aesthetics and Regenerative Medicine. They share what motivated them to lead, how they're championing safe practices in medical aesthetics, and the importance of compliance education in building a safer, stronger med spa community. Make a difference in your local med spa community by joining your state chapter today. --- Music by Ghost Score

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10 What do you think about the leadership? 23:44 Let's talk about sustainability. Tell us about the medical device industry's collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59 Let's talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53 Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20 Preview of episode 33 39:27 Give us your feedback 40:23 Team Mah-rvel: the Party for a Purpose 40:41 Thanks 40:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA). Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.

Send us a textIn today's episode of the I AM Well MD podcast, we are thrilled to welcome Dr. Sharon L. Stein, MD, FACS, FASCRS, a renowned colorectal surgeon, educator, and leader in the field of surgery. Dr. Stein brings a wealth of knowledge and a powerful perspective on diversity, leadership, and overcoming challenges in the medical field. She shares her non-traditional path to becoming a leading colorectal surgeon, her experience in balancing family and career, and the important role that intention played as she built her beautiful life. The wisdom she shares is invaluable: life doesn't need to just “happen” to you – living with thoughtful intention can help transform your life in immeasurable ways.  In addition to her work as a surgeon, Dr. Stein is the founder of The Intentional Surgeon, where she provides professional development and leadership coaching to elevate surgeons and healthcare professionals worldwide. She shares her insights on leadership and growth through her podcast, The Intentional Surgeon, which can be found on your favorite podcast platforms or though her website. Whether you're a surgeon looking to enhance your leadership skills or someone interested in learning more about the intersection of personal development and career, this conversation with Dr. Stein is packed with valuable pearls. To learn more about Dr. Stein, you may visit her at: Website: https://www.intentionalsurgeon.com/Instagram: @slsteinmdwww.linkedin.com/in/sharonsteinmdwww.facebook.com/sharon.stein.355@IntentionalSurgeon.bsky.socialDr. Tanikella practices General Pediatrics, Integrative Medicine, and is an expert in Mind-Body medicine. She has traveled the world to learn more about the intersection where mind, body, personal beliefs, and motivation meet. She is founder and CEO of Integrative Approaches to Mastering Wellness, where she brings the wisdom of mind body medicine and the power of life coaching together to help her clients break through their glass ceilings. Want to learn more? Visit Dr. Tanikella at iamwellmd.com. You can also join our email list or drop us a message by going to iamwellmd.com/contact. You may just get a shout out in the next episode! Follow I AM Well MD on Instagram | LinkedIn | FacebookWelcome home!Disclaimer: While I am a practicing physician, in this space, I function as a life coach and wellness advocate. The information provided here is for educational purposes only and does not necessarily reflect that of my employers. If you need medical or psychological services, I strongly recommend that you contact your physician. If you are having an emergency, please call 911 and proceed to the ER.

In this eye-opening video, Dr. Kristi Funk unveils the shocking truth about chicken and its connection to breast cancer. Learn how cooked meats like chicken contain harmful compounds like FIP, which fuel breast cancer growth. Discover how eliminating meat can drastically reduce these risks within just 24 hours. Don't miss this vital information for your health! #BreastCancerAwareness #HealthyEating #CancerPrevention

In a conversation with CancerNetwork®, Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS, discussed the key findings from a study she published in JAMA Network Open, which demonstrated that most patients with inflammatory breast cancer do not receive all available types of guideline-concordant care they are eligible for. Additionally, data showed disparities regarding receipt of modality-specific therapy among patients who were Black, Asian, Hispanic, or other racial minority populations. Based on these findings, Fayanju highlighted potential next steps for mitigating these gaps in care for certain patients with breast cancer. These strategies included revising stringent inclusion criteria for clinical trial enrollment, which may disproportionately exclude racial minority populations who have higher rates of diabetes or other medical conditions. Fayanju also emphasized educating clinicians across different oncology specialties to recognize how different populations present with inflammatory breast cancer and better understand the context in which patients receive treatment. “I hope [the study] makes some people angry…Frustration can be a wonderful fuel,” Fayanju stated regarding her research. “[By] recognizing that there isn't as much guideline-concordant care receipt amongst all people as there should be and the hope that's provided when we achieve concordant care, we can mitigate and eliminate racial disparities. I hope [that] will motivate people to think about how we can get more guideline-concordant care to more people and how we can incorporate diverse populations in the development of guidelines for concordant care at the beginning. Then, how can we also develop treatments that achieve efficacious results across diverse populations?” Fayanju is the Helen O. Dickens Presidential Associate Professor, chief in the Division of Breast Surgery at Penn Medicine, surgical director of Rena Rowan Breast Center, director of Health Equity Innovation at Penn Center for Cancer Care Innovation (PC3I), and senior fellow at Leonard Davis Institute of Health Economics (LDI), Perelman School of Medicine at the University of Pennsylvania. Reference Tadros A, Diskin B, Sevilimedu V, et al. Trends in guideline-concordant care for inflammatory breast cancer. JAMA Netw Open. 2025;8(2):e2454506. doi:10.1001/jamanetworkopen.2024.54506

   What if protecting a soldier's vision was as critical as shielding them from bullets? Join us as we promise a journey with retired Army Colonel and ophthalmologist, Dr. Robert Mazzoli, whose remarkable career in military medicine sheds light on the evolution of ophthalmology on the battlefield. Dr. Mazzoli's story, from his humble beginnings in Louisville, Kentucky to his pivotal role in military ophthalmology, offers an inspiring testament to the importance of education and adaptability in the face of changing warfare dynamics.    Discover the fascinating advancements in eye protection technology, as we trace the journey from the Vietnam War's primitive solutions to today's sophisticated polycarbonate eyewear. This conversation uncovers the cultural shifts and scientific breakthroughs that have revolutionized eye safety for military personnel. Dr. Mazzoli shares his insights into the complexities of treating ocular trauma and the transformative impact of regenerative medicine and telemedicine, which are reshaping how ocular injuries are managed in remote and hostile environments.    As we explore the challenges of vision rehabilitation within both military and VA systems, we address the ongoing efforts to integrate military ocular trauma expertise into civilian care. Dr. Mazzoli's perspective on the necessity of collaboration highlights the potential for military innovations to benefit the larger healthcare community. This episode is a compelling exploration of the past, present, and future of military ophthalmology, emphasizing the critical need for specialized training and collaborative care in ensuring the vision survival of soldiers.   Chapters: (00:03) Military Medicine and Ophthalmology Evolution (16:02) Advancements in Eye Protection Technology (26:03) Enhancing Ophthalmology in Military Deployments (31:11) Complex Care of Ocular Trauma (44:50) Vision Rehabilitation Challenges and Progress (51:12) Transformative Impact of Military Ophthalmology   Chapter Summaries: (00:03) Military Medicine and Ophthalmology Evolution Retired Army Colonel and ophthalmologist Dr. Robert Mazzoli discusses the role of ophthalmologists in combat, ocular injuries, and future advancements in regenerative medicine and telemedicine.   (16:02) Advancements in Eye Protection Technology Evolution of warfare, advancements in eye protection, challenges in adoption, and influence of modern military culture.   (26:03) Enhancing Ophthalmology in Military Deployments Evolution of military ophthalmology from Vietnam War to modern conflicts, challenges in providing care, advancements in deployment kits, and future needs for ocular injury management on a mobile battlefield.   (31:11) Complex Care of Ocular Trauma Ophthalmology subspecialties, ocular trauma in military settings, need for collaboration, damage control, and adaptability in deployed settings.   (44:50) Vision Rehabilitation Challenges and Progress Military and VA face challenges in coordinating vision rehab, relying on VA facilities and exploring advancements in regenerative medicine.   (51:12) Transformative Impact of Military Ophthalmology Telemedicine transforms military eye care, allowing collaboration and integration for ocular trauma treatment globally and in civilian systems.   Take Home Messages: The Critical Role of Vision in Combat: The episode underscores the essential role of vision for combat effectiveness. Vision is vital on the battlefield, with the potential to drastically impact a soldier's ability to perform and survive. The podcast highlights the strategic importance of protecting soldiers' eyesight to maintain operational readiness and effectiveness. Advancements in Eye Protection Technology: The journey of eye protection technology from early ineffective designs to modern polycarbonate solutions is explored. These advancements have significantly enhanced eye safety for military personnel, reducing the occurrence and severity of ocular injuries in combat zones. Challenges and Innovations in Military Ophthalmology: The evolution of military ophthalmology from past conflicts to the present is examined, emphasizing the need for comprehensive care and specialized training. The discussion touches on the importance of adapting to evolving warfare dynamics and the future potential of telemedicine and regenerative medicine in providing efficient ocular trauma care. Complexity of Ocular Trauma Care: The podcast delves into the intricacies of managing ocular trauma in military settings, highlighting the necessity for collaborative efforts among various ophthalmology subspecialists. The challenges of dealing with blast injuries and the importance of damage control ophthalmology are discussed, emphasizing the need for well-rounded ophthalmologists in deployed environments. Vision Rehabilitation and Future Prospects: The episode addresses the logistical and organizational challenges of vision rehabilitation within military and VA systems, especially for those affected by ocular trauma. It also explores the promising, yet early-stage, advancements in regenerative medicine, including stem cell research and whole eye transplants, as potential future solutions for vision restoration.   Episode Keywords: Military Ophthalmology, Dr. Rob Mazzoli, eye care advancements, vision rehabilitation, battlefield medicine, eye protection technology, telemedicine in military, regenerative medicine, ocular trauma care, military healthcare, veteran eye health, combat zone innovations, polytrauma management, military deployments, ocular innovation   Hashtags: #MilitaryMedicine #Ophthalmology #EyeCare #VisionOnTheFrontlines #Telemedicine #RegenerativeMedicine #BattlefieldInnovation #EyeProtection #VeteranHealth #CombatVision Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast    

In this episode, Eric Gantwerker, MD, MMSc(MedEd), FACS, AFAMEE - Pediatric Otolaryngology, Cohen Children's Medical Center at Northwell Health; Associate Professor, Department of Otolaryngology, Zucker School of Medicine at Hofstra/Northwell, shares his insights on transforming surgical education through technology, virtual reality, and AI.

In this episode, Eric Gantwerker, MD, MMSc(MedEd), FACS, AFAMEE - Pediatric Otolaryngology, Cohen Children's Medical Center at Northwell Health; Associate Professor, Department of Otolaryngology, Zucker School of Medicine at Hofstra/Northwell, shares his insights on transforming surgical education through technology, virtual reality, and AI.

In this episode, ACS Committee on Trauma (COT) Chair Jeffrey D. Kerby, MD, PhD, FACS, and Rural Trauma Committee Program Lead Michael Person, MD, FACS, discuss key takeaways and lessons learned from the recent COT Annual Meeting in Chicago. They talk about the 10th anniversary of the Future Trauma Leaders Program, pre-hospital blood protocols, the importance of a rural trauma system, and trauma readiness in the United States in the event of a mass population event.   PARTICIPANTS: Jeffrey D. Kerby, MD, PhD, FACS, Chair of the ACS Committee on Trauma, Birmingham, Alabama Michael Person, MD, FACS, COT Region Chief, Sioux Falls, South Dakota   Talk about the podcast on social media using the hashtag #HouseofSurgery

Tracy Gapin, MD, FACS, is a renowned expert in men's health optimization and longevity, with over 25 years of experience as a board certified urologist. He founded the Gapin Institute to help high-performing individuals, including entrepreneurs, executives, and athletes, achieve peak performance through personalized health programs. Dr. Gapin integrates advanced diagnostics, epigenetics, hormone therapy, and wearable technology to monitor and transform his clients' health, focusing on sustainable, measurable outcomes.A thought leader and author of bestsellers Male 2.0 and Codes of Longevity, Dr. Gapin has been featured on NBC, Entrepreneur Magazine, and at Dave Asprey's Biohacking Conference. He is a member of the American Academy of Anti-Aging, the Age Management Medical Group, Longevity Docs and the International Peptide Society.Learn more: https://gapininstitute.com/Sizzle Reel – https://www.youtube.com/watch?v=fdwSZvdDEiQLaunch Page – https://gapininstitute.com/launch (useful information and free gifts included!)Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-tracy-gapin-md-founder-of-gapin-institute

Tracy Gapin, MD, FACS, is a renowned expert in men's health optimization and longevity, with over 25 years of experience as a board certified urologist. He founded the Gapin Institute to help high-performing individuals, including entrepreneurs, executives, and athletes, achieve peak performance through personalized health programs. Dr. Gapin integrates advanced diagnostics, epigenetics, hormone therapy, and wearable technology to monitor and transform his clients' health, focusing on sustainable, measurable outcomes.A thought leader and author of bestsellers Male 2.0 and Codes of Longevity, Dr. Gapin has been featured on NBC, Entrepreneur Magazine, and at Dave Asprey's Biohacking Conference. He is a member of the American Academy of Anti-Aging, the Age Management Medical Group, Longevity Docs and the International Peptide Society.Learn more: https://gapininstitute.com/Sizzle Reel – https://www.youtube.com/watch?v=fdwSZvdDEiQLaunch Page – https://gapininstitute.com/launch (useful information and free gifts included!)Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-tracy-gapin-md-founder-of-gapin-institute

Douglas W. Lundy, MD, MBA, FACS, FAOA, discussed the future of orthopaedic trauma with William T. Obremskey, MD, FAOA, Director of Orthopaedic Trauma at Vanderbilt University Medical Center. Dr. Obremskey shares his vision for the future of orthopaedic trauma surgery, focusing on reducing complications through advanced technologies and improved practices.Perhaps most thought-provoking is Dr. Obremskey's perspective that some of the most impactful advances may not come from fancy technology at all—but from addressing underlying patient factors like smoking cessation and blood sugar control that dramatically affect healing outcomes. The future of trauma care involves both cutting-edge science and fundamental public health initiatives working in tandem.

In today's episode, we had the pleasure of speaking with Neal Shore, MD, FACS, about prostate cancer management and the use of androgen receptor (AR)–directed therapies. Dr Shore is the medical director for the Carolina Urologic Research Center in Myrtle Beach, South Carolina.  In our exclusive interview, we sat down with Dr Shore during the 2025 Bridging the Gaps in Prostate Cancer meeting to discuss the importance of multidisciplinary meetings to address unmet needs for patients with prostate cancer, the need for treatment strategies that improve upon the activity of current standards of care in this disease, the evolving roles of neoadjuvant and adjuvant therapies, and the significance of biomarkers and imaging. He also highlighted treatment advances that have been achieved with AR-directed agents, such as apalutamide (Erleada) and darolutamide (Nubeqa), along with considerations for the optimal intensification and de-intensification of these agents to balance efficacy and quality of life. 

“Can they even call it that anymore?” Yes, we can because diversity is not a dirty word. It represents a healthy ecosystem. Diversity is better for forests, microbiomes, ocean-dwelling species, T cell function, and yes the workforce. Join Susanne G. Warner, MD and LaDonna Kearse, MD for a conversation with three phenomenal surgical oncologists and leaders — Callisia Clarke, MD, MS, FACS, FSSO, John H. Stewart IV, MD, MBA, FACS, and Sarah Shubeck, MD — as they explore how to build teams that synergize toward maximized potential, how to navigate the discomfort of actual change, and how to be about it when not everyone will talk about it.

In this episode, trauma surgeon Dany Westerband, MD, FACS, talks with John Sutyak, MD, FACS, and Joakim Jorgensen, MD, FACS, about the recent ACS Advanced Trauma Life Support (ATLS) Global Symposium that attracted 400 people from 48 countries. The meeting was held in Chicago in March 2025. They discuss key takeaways from the symposium and preparations to launch ATLS 11 later this year.    HOST: Dany Westerband, MD, FACS, ATLS International Program Director from Silver Spring, Maryland    GUESTS: John Sutyak, MD, FACS, member of the ACS Committee on Trauma Executive Committee and ATLS Chair, from Springfield, Illinois  Joakim Jorgensen, MD, FACS, ATLS Region Chief from Hovik, Norway    Talk about the podcast on social media using the hashtag #HouseofSurgery 

Brian Case of FACS returns to Car Con Carne, not long after the release of the band’s incredible 6th album, “Wish Defense,” and before they play Thalia Hall on April 17. We talk about Steve Albini’s role in the recording, as “Wish Defense” was the last thing he worked on before his untimely passing last year. We also talk about the ambiguity of Brian’s lyrics, the cool sounds the band makes, and the fact that they recorded the songs live to tape - holy shit. ## Car Con Carne is sponsored by Easy Automation: easy-automation.net Transform your living space with cutting-edge home automation. Experience seamless control over audio/video, lighting, climate, security, and more. Embrace the future of smart living – your home, your rules. Get a quote by visiting easy-automation.net, or give Dan a call at 630.730.3728 ## On Thursday, April 3, join me for a live recording of Car Con Carne at Legit Dogs and Ice in South Elgin - 322 S. Randall Road. Yeah, I know it’s a school night, but I’ll be featuring live performances and interviews with East Moon, Ricky Liontones Revue and more! It starts at 8:30 pm. Doors at 7:30 - we start recording the podcast at 8:30. Hope to see you there.See omnystudio.com/listener for privacy information.

The February 2025 New Music Train is on the tracks and heating up the rails! In this episode, we hear from Harris King, complete with train platform sound effects. As we head down the tracks, Harris discusses new releases from FACS, Deep Sea Diver and The Chills. Rockin' the Suburbs on Apple Podcasts/iTunes or other podcast platforms, including audioBoom, Spotify, Google Podcasts, Amazon, iHeart,Djinn RecordsStitcher and TuneIn. Or listen at SuburbsPod.com. Please rate/review the show on Apple Podcasts and share it with your friends. Visit our website at SuburbsPod.com Email Jim & Patrick at rock@suburbspod.com Follow us on the Threads, Facebook or Instagram @suburbspod If you're glad or sad or high, call the Suburban Party Line — 612-440-1984. Theme music: "Ascension," originally by Quartjar, next covered by Frank Muffin and now re-done in a high-voltage version by Quartjar again!  Visit quartjar.bandcamp.com and frankmuffin.bandcamp.com.

In this episode, I sit down with Dr. Kristy Hamilton, a board-certified plastic surgeon, to explore the latest advancements in aesthetic medicine, the impact of social media on beauty standards, and the reality of breast implant illness. Dr. Hamilton shares her expert insights on facial rejuvenation, fat transfer, the safety of fillers, and new biostimulators while debunking common myths around plastic surgery. We also dive deep into the controversial rise of explant surgeries, the latest data on BII, and how surgical and non-surgical options can help individuals feel more confident in their skin. From the influence of celebrity procedures to the evolution of breast implants, this conversation is packed with science-backed insights, expert advice, and practical takeaways for those considering aesthetic procedures.Key Points: The truth behind plastic surgery and celebrity transformationsWhat can and can't be fixed through diet, exercise, and non-surgical treatmentsBreast Implant Illness: What the latest research revealsThe risks of capsulectomy and explant regretThe role of fillers, biostimulators, and fat transfer in facial rejuvenationHow to approach facelifts and natural aesthetic treatmentsBest skincare practices for long-term anti-agingWho is Dr. Kristy Hamilton? Kristy Hamilton, MD, FACS is a plastic and reconstructive surgeon in Houston, Texas who specializes in aesthetic surgery of the face, breast, and body. An artist and a scientist, Dr. Hamilton blends form and function with an artistic eye to achieve beautiful, natural results. She understands patients' individual needs and applies her surgical skill with meticulous detail, customized to each patient's anatomy. Her patients' well-being is her utmost concern, and she is well known for her compassionate care.Dr. Hamilton offers the full range of bespoke aesthetic plastic surgery including rhinoplasty, eyelid surgery, facelifts and facial rejuvenation, necklifts, fat transfer, chin surgery, breast augmentation and lifts, body contouring and liposuction, as well as reconstructive facial and breast surgery.This episode is brought to you by: LMNT - Code DRLYON for free LMNT Sample Pack! - http://drinklmnt.com/drlyonAG1 - Code DRLYON for FREE Welcome Kit and Starter Packs! - https://drinkAG1.com/DRLYONOur Place - Code DRLYON for 10% off - https://fromourplace.comTimeline - Code DRLYON for 10% OFF - https://timelinenutrition.com/DRLYONFind Dr. Kristy Hamilton at: Website: https://www.drkristyhamilton.com/ Instagram: https://www.instagram.com/drkristyhamilton/ LinkedIn:

Join the Behind the Knife Surgical Oncology Team as we discuss the presentation, work-up, and management of neuroendocrine tumors of the small bowel. Learning Objectives: In this episode, we review the basics of neuroendocrine (NE) tumors of the small bowel, including how to evaluate patients with presenting symptoms consistent with NE tumors, initial work-up, staging, and management.  We discuss key concepts including DOTATATE scans and medical therapies high yield for direct patient care and board exams.  Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. Connor Chick, MD (@connor_chick) is a 2nd Year Surgical Oncology fellow at Ohio State University. Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 1st Year Surgical Oncology fellow at MD Anderson. Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center Links to Paper Referenced in this Episode: Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. PMID: 28076709; PMCID: PMC5895095. https://pubmed.ncbi.nlm.nih.gov/28076709/ ***SPECIALTY TEAM APPLICATION LINK: https://docs.google.com/forms/d/e/1FAIpQLSdX2a_zsiyaz-NwxKuUUa5cUFolWhOw3945ZRFoRcJR1wjZ4w/viewform?usp=sharing Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.